HYPAZ: Hypertension Induced by Pazopanib
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Study of ADI-PEG 20 in Patients With Relapsed Sensitive or Refractory Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pazopanib in Patients With Relapsed or Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of IMGN901 for Patients With Advanced Solid Tumors and Extensive Stage Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
TF2- Small Cell Lung Cancer Radio Immunotherapy
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation
- Status
- COMPLETED
- Phase
- N/A
Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Circulating Tumor Cells (CTCs) as a Blood-based Tumor Marker in Patients With Small Cell Lung Cancer (SCLC)
- Status
- COMPLETED
- Phase
- N/A
Study of Hypofractionated Proton Radiation Therapy in Thoracic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Study of Sorafenib Maintenance in Patients With ED-SCLC After Response to Induction Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Early Versus Late Concurrent Chemoradiation for Limited Stage Small-cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of Peptide Cancer Vaccine To Treat HLA-A*24-positive Advanced Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacogenomics ANDA SNP Clinical Study - Etoposide and Single Nucleotide Polymorphisms
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Alisertib in Adults With Nonhematological Malignancies, Followed by Alisertib in Lung, Breast, Head and Neck or Gastroesophageal Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Observational Study of CPT-11 Plus Platinum Analogues Regimens and UGT1A1 Genotypes in Solid Tumors
- Status
- COMPLETED
- Phase
- N/A
A Study for Participants With Small-Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chloroquine as an Anti-Autophagy Drug in Stage IV Small Cell Lung Cancer (SCLC) Patients
- Status
- TERMINATED
- Phase
- PHASE1
Carboplatin and Etoposide Plus LBH589 for Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1